(5R)-5-hydroxytriptolide (LLDT-8), a novel immunosuppressant in clinical trials, exhibits potent antitumor activity via transcription inhibition

✍ Scribed by Lei Wang; Yongping Xu; Li Fu; Yuanchao Li; Liguang Lou

• Book ID: 116335913
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 815 KB
• Volume: 324
• Category: Article
• ISSN: 0304-3835
• DOI: 10.1016/j.canlet.2012.05.004